Cite
Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.
MLA
Uhlig, Annemarie, et al. “Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.” CardioVascular & Interventional Radiology, vol. 41, no. 2, Feb. 2018, pp. 277–83. EBSCOhost, https://doi.org/10.1007/s00270-017-1816-9.
APA
Uhlig, A., Hahn, O., Strauss, A., Lotz, J., Trojan, L., Müller-Wille, R., & Uhlig, J. (2018). Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy. CardioVascular & Interventional Radiology, 41(2), 277–283. https://doi.org/10.1007/s00270-017-1816-9
Chicago
Uhlig, Annemarie, Oliver Hahn, Arne Strauss, Joachim Lotz, Lutz Trojan, René Müller-Wille, and Johannes Uhlig. 2018. “Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.” CardioVascular & Interventional Radiology 41 (2): 277–83. doi:10.1007/s00270-017-1816-9.